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doi:10.1016/j.jtcvs.2004.03.021Objective: Hemodynamic performances of mechanical valve prostheses in patients
with aortic valve stenosis and a small aortic annulus are crucial. We analyzed the in
vitro hydrodynamics of 5 currently available bileaflet mechanical prostheses that
fitted a 21-mm-diameter valve holder of a Sheffield pulse duplicator.
Methods: Three samples of 5 high-performance production-quality prostheses,
including the sewing ring cuffs, were tested in the aortic chamber of a Sheffield
pulse duplicator. Sizes of the prostheses fitting the 21-mm valve holder were as
follows: 18-mm ATS, 19-mm SJM Regent, 19-mm Sorin Bicarbon Slimline, 19-mm
On-X, and 21-mm Carbomedics Top Hat. The tests were carried out at a fixed pulse
rate (70 beats/min) and at increasing cardiac outputs of 2, 4, 5, and 7 L/min. Each
valve was tested 10 times for each different cardiac output. This resulted in a total
of 40 tests for each valve and 120 tests for each valve model. The aortic pressure
was set at 120/80 mm Hg (mean pressure, 100 mm Hg) throughout the experiment
for all cardiac outputs. Forward flow pressure decrease, total regurgitant volume,
closing and leakage volumes, effective orifice area, and stroke work loss were
recorded while the valve operated under each cardiac output.
Results: The SJM Regent valve and the Sorin Bicarbon Slimline prosthesis showed
the lowest mean and peak gradients at increasing cardiac outputs. The closure
volume was higher for the SJM Regent and Sorin Bicarbon Slimline prostheses,
unlike with the ATS prosthesis at 7 L/min of cardiac output. The ATS and SJM
Regent prostheses showed the largest regurgitant volume, whereas the Sorin Bicar-
bon Slimline prosthesis showed the lowest regurgitant volume. The calculated
effective orifice area and stroke work loss were significantly better with the SJM
Regent and Sorin Bicarbon Slimline prostheses.
Conclusion: Assuming that the 21-mm valve holder in which all the tested pros-
theses were accommodated is comparable with a defined aortic valve size, this
hydrodynamic evaluation model allowed us to compare the efficiency of currently
available valve prostheses, and among these, the SJM Regent and the Sorin
Bicarbon Slimline exhibited the best performances.
The presence of a small aortic annulus might force cardiac surgeons toenlarge the annulus or to implant a small prosthesis. The latterstrategy might lead to unsatisfactory pressure gradients across theprosthesis, with consequent incomplete left ventricular hypertrophyregression.1 Nevertheless, aortic root enlargement procedures mighthave double the operative mortality compared with that of standard
2,3aortic valve replacement. Very recently, excellent results with normalization of
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aortic prosthesis have been reported,4 suggesting the need
for care in applying more complex procedures.
Refinement in hemodynamic performances of mechani-
cal valve prostheses is crucial and might be a continuously
challenging task. However, the ability to develop and re-
lease new heart valve prosthetic models might clash with
the possibility that new valve models could face structural
failure.5 Careful in vitro hydrodynamic evaluation and con-
tinuous monitoring of patients with new prostheses are
therefore mandatory. Comparison of hydrodynamic perfor-
mances of currently available prostheses is somehow mis-
leading because of differences in reporting nominal valve
size, which is not uniform across manufacturers.6
In this report we analyze the hydrodynamic perfor-
mances of 5 high-performance bileaflet mechanical prosthe-
ses (SJM Regent, Sorin Bicarbon Slimline, Carbomedics
Top Hat, On-X, and ATS), which, regardless of the manu-
facturer’s nominal size, were fitted on a 21-mm-diameter
valve holder of a Sheffield pulse duplicator (SPD).
Material and Methods
The SPD is a system designed to perform pulsatile hydrodynamic
testing of prosthetic heart valves by means of continuous measure-
ment of flow and transvalvular pressure gradients. The system has
been previously described in detail.7
Production-quality prostheses, including the sewing ring cuffs,
were tested in the aortic chamber of the SPD. Prosthetic valve
characteristics, geometric profiles, geometric orifice areas, and
clear areas of tested valves8 are reported in Table 1. To allow a
meaningful comparison regardless of nominal size, we tested valve
prostheses that could be accommodated in a 21-mm valve holder.
The valves and the holder were not sealed before testing because
the holder and the sewing ring fitted perfectly. Therefore paraval-
vular leakage was not allowed in any test, and the sealing was
considered unnecessary. The sizes of the tested valves were as
follows: 18-mm ATS, 19-mm SJM Regent, 19-mm Sorin Bicarbon
Slimline, 19-mm On-X, and 21-mm Carbomedics Top Hat. The
valves were tested according to previously reported standard pro-
tocols.8,9
The system was filled with saline solution (0.9%), as recom-
mended by the manufacturer, to optimize measurements (Instruc-
tion Manual, Sheffield Pulse Duplicator, Department of Medical
TABLE 1. Geometrics of the tested valves and mean value
Model
External
diameter
(mm)
Internal
diameter
(mm)
Height
(mm)
E
a
ATS 18.2 16.8 8.8
Carbomedics Top Hat 21.8 16.7 10.3
On-X 20.1 17.4 10.8
SJM Regent 19 17.8 9.07
Sorin Slimline 19.2 17.22 10.5
EOA, Effective orifice area.Physics and Clinical Engineering, The University of Sheffield).
458 The Journal of Thoracic and Cardiovascular Surgery ● SeptThree production-quality samples of each bileaflet model were
tested. The tests were carried out at a single pulse rate (70 beats/
min) with a cardiac output (CO) of 2, 4, 5, and 7 L/min according
to ISO584010 and US Food and Drug Administration Replacement
Heart Valve Guidance protocols.11 Each valve was tested 10 times
at each different CO. This resulted in a total of 40 tests for each
valve and 120 tests for each valve model. The mean and SD of
each measurement parameter for each test condition was calcu-
lated from the 10 repeated tests on each valve. Because the
diastolic interval was 555 ms, whereas the systolic interval was
300 ms in every case, mean systolic flow rate was only related to
CO. Stroke volume of the pump and systemic resistance and
compliance were adjusted to obtain the target CO and character-
istic aortic pressure waveforms. The aortic pressure was kept
constant at 120/80 mm Hg (mean pressure, 100 mm Hg) through-
out the experiment for all COs. Simultaneous pressure measure-
ments were recorded by using electromagnetic flowmeters and
pressure transducers located 30 mm upstream and 100 mm down-
stream of the aortic valve. The following parameters were deter-
mined for each cardiac cycle: forward flow pressure decrease (P),
closing volume (in milliliters), leakage volume (in milliliters), total
regurgitant volume (in milliliters), effective orifice area (EOA; in
square centimeters), stroke work loss (in percentages), and valvu-
lar resistance (in (dynes · s · cm5).
Forward flow pressure decrease, closing volume, leakage vol-
ume, total regurgitant volume, and EOA were calculated as pre-
viously published by Walker and coworkers.8 Valvular resistance
and stroke work loss were calculated as the ratio of the mean
transprosthetic gradient to the mean systolic ventricular pressure,
as previously published by Voelker and colleagues.9 All data were
expressed as means  SD. The 2 test was used for statistical
comparison.
Results
The obtained mean values and SDs are expressed according
to the 4 COs adopted and reported in Table 2.
Pressure Differences
The mean and peak pressure differences for each CO are
reported in Figure 1. The SJM Regent valve and the Sorin
Bicarbon Slimline prosthesis at COs of 5 and 7 L/min
showed the lowest gradients. The results with such valves
were significantly lower than those observed with the Car-
OA calculated over all tests performed for each valve
ion
(°)
Opening
angle (°)
Geometric
orifice area
(cm2)
Clear valve
area (cm2) EOA (cm2)
85 2.02 – 1.44
78 2.07 1.46 1.45
90 2.22 2.00 1.80
85 2.39 1.96 1.78
70 2.27 – 1.59of E
xcurs
ngle
60
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60
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ETdifference was more evident at a CO of 5 L/min and
increased to a maximal level at 7 L/min.
Regurgitant Volumes
The observed total regurgitant volumes are reported in
Figure 2. The Sorin Bicarbon Slimline valve showed the
lowest regurgitant volume (5 mL), which was signifi-
cantly smaller for each CO when compared with that ob-
TABLE 2. Hydrodynamic performances of the tested valve
Model CO (L/min)
MSPD
(mm Hg)
PSPD
(mm Hg)
ATS 2.00 4.55 2.44 8.77 2.6
4.00 11.20 2.8 21.55 3.16
5.00 15.28 2.96 30.29 3.77
7.00 27.72 3.32 53.94 4.61
Carbomedics 2.00 3.81 1.23 8.65 1.52
4.00 9.96 1.86 19.36 2.01
5.00 15.05 2.05 30.02 2.52
7.00 28.21 2.23 58.05 3.4
ONX 2.00 2.72 2.07 6.48 2.87
4.00 9.59 3.8 20.51 5.25
5.00 14.47 4.33 30.9 5.46
7.00 26.5 3.06 54.8 4.89
Regent 2.00 2.64 0.92 8.42 0.68
4.00 7.65 0.35 17.91 0.99
5.00 8.69 0.82 19.28 1
7.00 15.66 0.75 33.16 0.98
Sorin 2.00 4.16 1.57 9.99 1.72
4.00 7.92 1.65 15.59 1.66
5.00 10.42 2.21 20.96 2.49
7.00 17.17 4.19 34.40 4.93
CO, Cardiac output; MSPD, mean systolic pressure difference; PSPD, peak
volume; EOA, effective orifice area; SWL, stroke work loss.
Figure 1. A, Mean systolic pressure difference. The SJ
at a CO of 5 and 7 L/min showed the lowest gradients. B
and the Sorin Bicarbon Slimline prosthesis at COs oftained with the other valves (P .0001). The ATS and SJM
The Journal of ThoraciRegent valves showed the highest regurgitant volume (9
mL). The observed trend was toward a reduction of regur-
gitant volume at increasing CO, unlike the ATS prosthesis,
which exhibited an increased regurgitant volume at 7 L/min
of CO.
Closure Volume
The recorded closure volumes are reported in Figure 3. All
an value  SD) at COs of 2, 4, 5, and 7 L/min
TRV (mL) VLV (mL) EOA (cm2) SWL (%)
8.87 1.09 6.92 1.03 1.51 1.26 4.65 2.52
8.21 0.73 7.26 0.78 1.36 0.21 11.20 2.73
7.70 1.06 6.74 1.24 1.44 0.15 14.82 2.76
9.11 1.4 7.45 0.8 1.49 0.11 24.15 2.66
7.04 0.7 5.69 0.6 1.52 2.3 3.97 1.25
6.86 0.55 5.90 0.47 1.41 0.16 10.24 1.74
7.53 0.53 6.29 0.54 1.43 0.11 14.72 1.74
6.57 0.52 5.66 0.41 1.45 0.06 24.92 1.34
6.4 0.96 5.15 1.01 2.17 1.66 2.96 2.22
6.13 1.05 5 1.14 1.52 0.34 9.78 3.65
6.46 1.32 5.44 1.3 1.5 0.46 14.35 3.82
5.83 1.13 5.05 0.99 1.5 0.07 24 2.05
8.75 2.2 5.97 1.83 1.41 0.34 2.93 0.98
8.84 2.2 7.15 2.3 1.85 0.05 8.31 0.38
8.64 1.61 6.95 1.61 1.90 0.10 9.15 0.8
7.90 1.6 6.69 1.6 1.97 0.04 15.43 0.61
4.45 1.28 2.73 1.18 1.12 0.23 4.76 1.75
4.02 0.69 2.66 0.86 1.60 0.15 8.78 1.91
4.34 0.88 2.78 0.89 1.76 0.25 11.29 2.34
3.86 0.83 2.58 0.99 1.89 0.21 17.42 3.54
lic pressure difference; TRV, total regurgitant volume; VLV, valve leakage
gent valve and the Sorin Bicarbon Slimline prosthesis
ak systolic pressure difference. The SJM Regent valve
7 L/min showed the lowest gradients.s (me
systoM Re
, Pe
5 andthe tested valves showed a decreasing closure volume as CO
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increased. The highest value was observed with the SJM
Regent prosthesis. At lower COs, the SJM Regent valve had
a significantly higher closure volume when compared with
those of the other prostheses. On the other hand, when
increasing the CO between 5 and 7 L/min, the closure
volumes obtained with the SJM Regent and the Sorin Bi-
carbon Slimline prostheses were comparable, and such re-
sults were significantly higher than those obtained with the
other prostheses (P  .0001). The ATS valve showed a
peculiar trend: as expected, with increasing CO, the closure
volume decreased, but at greater than 5 L/min of CO, a
curve inversion was detected.
Leakage Volume
The grade of the leakage volume for each tested valve is
Figure 2. Total regurgitant volume. The Sorin Bicarbon Slimline
valve showed the lowest total regurgitant volume, whereas the
ATS and SJM Regent valves showed the highest total regurgitant
volume.
Figure 3. Closure volumes. All the tested valves showed a de-
creasing closure volume as CO increased. The highest value was
observed with the SJM Regent prosthesis.reported in Figure 4. The Sorin Bicarbon Slimline valve
460 The Journal of Thoracic and Cardiovascular Surgery ● Septshowed the lowest leakage volume, which was significantly
smaller for each CO when compared with that obtained with
the other valves (P  .0001). All the tested prostheses but
the SJM Regent showed a stable leakage volume at in-
creased CO. The highest leakage volume was observed with
the ATS valve. The SJM Regent prosthesis had a peculiar
trend, with an increasing leakage volume of between 2 and
4 L/min, which remaining stable thereafter. Unlike the Sorin
Bicarbon Slimline valve, all the other models showed a
leakage volume greater than the closure volume.
Effective Orifice Area
The calculated EOAs for all valves are reported in Figure 5.
The On-X prosthesis showed a different trend when com-
pared with the other valves. It had the highest EOA at the
lowest CO, with a decreasing area at increasing CO. On the
other hand, with the ATS and Carbomedics Top Hat pros-
theses, the calculated EOA was stable at increasing CO.
SJM Regent and Sorin Bicarbon Slimline prostheses had a
similar trend, showing the lowest EOA at 2 L/min of CO.
Increasing the CO the EOA improved, becoming signifi-
cantly higher than that of the ATS, On-X, and Carbomedics
Top Hat prostheses (P  .005).
Stroke Work Loss
The calculated stroke work loss values for each tested valve
are listed in Figure 6. The stroke work loss profile for each
valve was similar, increasing concurrently with the increase
of CO. The results obtained at 2 and 4 L/min were compa-
rable for all the prostheses. At 5 and 7 L/min, the SJM
Regent and Sorin Bicarbon Slimline prostheses showed the
Figure 4. Leakage volumes. The Sorin Bicarbon Slimline valve
showed the lowest leakage volume. The highest leakage volume
was observed with the ATS valve. Unlike the Sorin Bicarbon
Slimline prosthesis, all the other models showed a leakage
volume greater than the closure volume.best performances, which were significantly better than
ember 2004
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theses (P  .00001).
Discussion
Continuous refinement in hemodynamic performances of
mechanical valve prostheses is a challenging task. Compar-
ison of hydrodynamics of different valve prostheses is dif-
ficult because of the lack of standardization in labeling by
manufacturers.6 To allow a meaningful comparison that is
relevant for clinical application, we designed an innovative
study in concept to analyze the hydrodynamics of 5 differ-
ent high-performance bileaflet mechanical prostheses (SJM
Regent, Sorin Bicarbon Slimline, Carbomedics Top Hat,
On-X, and ATS). Assuming that a defined valve holder is
comparable with a defined aortic size annulus in which
several different nominally sized valves could be allocated,
we analyzed, at the SPD, 5 high-performance prostheses
that were possible to be allocated in a 21-mm valve holder.
This is the first article that strictly transfers the hydrody-
namic inferences in a setting of clinical utility and applica-
bility.
In patients with a small aortic annulus, insertion of small
prostheses might lead to higher residual pressure gradients
and incomplete left ventricular hypertrophy regression. The
clinical effect of such a condition is still controversial.1
Either different surgical procedures or hemodynamically
improved prosthetic valve devices have been proposed to
reduce transprosthetic gradients in such cases. Nevertheless,
when dealing with aortic root enlargement procedures,
Sommers and David3 and Carrier and colleagues2 observed
that operative mortality is twice that reported during stan-
Figure 5. Effective orifice area. The On-X prosthesis showed the
highest EOA at the lowest CO. The ATS and Carbomedics Top Hat
prostheses showed a stable EOA at increasing CO. The SJM
Regent and Sorin Bicarbon Slimline valves had the largest EOA at
increasing CO.dard aortic valve replacement. On the other hand, Freed and
The Journal of Thoraciassociates4 reported excellent results with normalization of
left ventricular mass in elderly women who received a small
aortic valve, including in their analysis woman who re-
ceived both mechanical and biologic tissue valves. The
authors’ final suggestion was to be careful with the more
complex procedures. In several institutional studies small
prosthetic size was not a risk factor for intermediate and
long-term survival.12-14
Hence the input to the research programs to maximize
the prostheses hydrodynamics and improve their clinical
performances was born. SJM Regent and Sorin Bicarbon
Slimline prostheses, according to our experimental results,
exhibited the smallest transprosthetic mean and peak gradi-
ents and the lowest stroke work loss.
These results are well explained for the SJM Regent
valve by using the evidence of the larger EOA, greater
geometric orifice area, and valve clear area when compared
with those values in the others prostheses. As previously
published, at 5 L/min of CO, the SJM Regent valve showed
the greatest closing volume, becoming comparable with the
others at 7 L/min. Nevertheless, among all tested valves, we
observed the lowest stroke work loss with the SJM Regent
valve. With the small valve size, the cause of energy loss
was largely the result of the forward flow transvalve pres-
sure difference, with less than 10% being the result of the
regurgitant flow,15 and these satisfactory results with the
SJM Regent depend mostly on the improved design and
increased geometric orifice area.
The Sorin Bicarbon Slimline prosthesis has the smallest
opening angle (70°) among the 5 tested valves, and because
of this peculiar design, it showed the lowest regurgitant
volume. Thereby the underlying cause for the hydrody-
namic success with the Sorin Bicarbon Slimline prosthesis
Figure 6. Stroke work loss. At 5 and 7 L/min, the SJM Regent and
Sorin Bicarbon Slimline prostheses showed the best perfor-
mances.should be found either not on the geometric orifice area,
c and Cardiovascular Surgery ● Volume 128, Number 3 461
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parable with that of On-X, or on the EOA, which was
smaller than that of both the SJM Regent and On-X pros-
theses, but mostly on the concave-convex leaflets design,
which seems to be a rather winning solution.
The worst hydrodynamic results, namely higher stroke
work loss obtained with the Carbomedics Top Hat and ATS
valves when compared with that of the SJM Regent and
Sorin Bicarbon Slimline prostheses, are well explained by
either the smaller geometric orifice area or the smaller
calculated EOA.
On the other hand, the results obtained with the On-X
valve are controversial and difficult to explain. In fact, the
On-X valve, which was designed to improve hydrodynamic
performance, unlike accredited of the largest clear orifice
area, the largest calculated EOA at lower CO, and the
greater opening angle (90°), showed results in terms of
regurgitant volumes, transprosthetic gradients, and stroke
work loss comparable with those of the Carbomedics Top
Hat and ATS valves and significantly inferior to those
obtained with the Sorin Bicarbon Slimline and SJM Regent
prostheses. Therefore further explanations, probably related
to the peculiar On-X prosthesis design (higher profile) or to
an incomplete valve opening, might be inferred.
In conclusion, according to our experimental model,
each of the tested valves could be accommodated on a
21-mm aortic annulus, but in the light of these in vitro
results, the best hemodynamic performances should be ob-
tained mostly with the SJM Regent and Sorin Bicarbon
Slimline prostheses.
Moreover, the clinical inference that we can draw from
the study is as follow: on the basis of either our experience
or the experience of other authors,16 a growing problem is
the surgical management of small women with a calcified
annulus. This hydrodynamic evaluation model, which is
strictly related to the surgical aspect, might be helpful in a
surgeon’s choice when dealing with such insidious cases.
We thank Giulio Rizzoli, MD, for his assistance in preparing
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